I/O might still be a couple of weeks away, but it’s a big day for new Google announcements anyway. The company announced a rebranding of its Fitbit app to Google Health today, as 9to5Google initially ...

Fastenal (FAST) — company embeds inventory infrastructure inside customer factories, creating durable, sticky relationships. Fastenal has paid uninterrupted quarterly dividends for 27+ years and ...

Bank of America upgraded Ulta Beauty (ULTA) stock to Buy, arguing that elevated investor expectations have reset to reasonable levels, creating a discount to own a high-quality compounder with durable ...

If you’re as online as many of the folks on the MotorTrend masthead, you’ve likely seen one of the many Honda Fit memes that populate social media’s infinite depths. In nearly all cases, users profess ...

'Mad Money' host Jim Cramer weighs if financial services platform StoneX is worth adding to your portfolio. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get ...

Robinhood must prove it is becoming a relationship-driven financial platform, not just a trading app that thrives in bull markets. Demographics must translate into durability. If earnings become more ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Aker BP offers a compelling dividend accumulation play, with a 9% yield and a 5% annual dividend growth target. AKRBF's low per-barrel oil exploration, lifting, and other production costs ensure ...

At least two Wall Street firms see good times ahead for TJX Cos. shares, despite a choppy stock market reaction to the Marshalls and T.J. Maxx parent's latest earnings Wednesday. Both Bernstein and ...

As a dividend growth investor, I'm not solely focused on a stock's starting yield. This is because, at 28 years old, I (Kody) presumably have plenty of time to compound. In other words, I'm more ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...